Patent ID: 7879816

Claim:
A method of treating cancer in a patient or subject in need thereof comprising administering to said patient an effective amount of at least one compound according to the structure: Where X is H or F; R 1 and R 2 are independently H, an acyl group, a C 1 -C 20 alkyl or ether group, a phosphate, diphosphate, triphosphate or a phospliodiester group, or a pharmaceutically acceptable salt thereof, wherein said cancer is stomach, colon, rectal, pancreatic, lung, breast, cervix uteri, corpus uteri, ovary, prostate, testis, bladder, renal, brain/CNS, head and neck, throat, Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, leukemia, melanoma, Ewing's sarcoma, small cell lung cancer, choriocarcinoma, rhabdomyosarcoma, Wilms' tumor, neuroblastoma, hairy cell leukemia, mouth/pharynx, oesophagus, larynx, kidney cancer and lymphoma cancer.